Mark Clemons Selected Research

Fulvestrant (Faslodex)

11/2018	Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.
1/2017	Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
6/2015	Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study.
11/2009	Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Clemons Research Topics

Disease

133	Breast Neoplasms (Breast Cancer) 02/2024 - 10/2002
45	Neoplasms (Cancer) 01/2024 - 11/2003
43	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2004
18	Pain (Aches) 01/2023 - 12/2004
16	Vomiting 12/2021 - 09/2007
14	Nausea 12/2021 - 09/2007
12	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 06/2007
7	Febrile Neutropenia 08/2021 - 12/2016
7	Triple Negative Breast Neoplasms 01/2018 - 02/2010
5	Arthralgia (Joint Pain) 10/2021 - 01/2016
4	Acute Pain 09/2018 - 01/2016
4	Bone Resorption 01/2010 - 10/2004
3	Infections 05/2021 - 11/2019
3	Lung Neoplasms (Lung Cancer) 11/2016 - 02/2009
3	Fatigue 03/2016 - 11/2003
3	Carcinoma (Carcinomatosis) 01/2016 - 08/2003
2	Dyspareunia 01/2023 - 07/2015
2	Pruritus (Itching) 01/2023 - 07/2015
2	Disease Progression 01/2023 - 12/2004
2	Hot Flashes 01/2020 - 08/2015
2	Myalgia 07/2018 - 01/2017
2	Exanthema (Rash) 01/2017 - 11/2016
2	Diarrhea 11/2016 - 12/2008
2	Spontaneous Fractures (Pathological Fracture) 08/2015 - 09/2007
2	Spinal Cord Compression 08/2015 - 09/2007
2	Bone Diseases (Bone Disease) 10/2013 - 07/2012
2	Neutropenia 01/2013 - 01/2010
2	Brain Neoplasms (Brain Tumor) 07/2012 - 11/2009
2	Neoplasm Micrometastasis 07/2012 - 06/2012
2	Hypercalcemia (Milk Alkali Syndrome) 02/2009 - 09/2007
2	Cognitive Dysfunction 06/2008 - 11/2003
1	Cardiac Arrhythmias (Arrythmia) 12/2021

Drug/Important Bio-Agent (IBA)

37	Diphosphonates (Bisphosphonates)IBA 06/2021 - 01/2004
14	Hormones (Hormone)IBA 02/2024 - 04/2008
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 02/2010
13	Zoledronic Acid (Zometa)FDA Link 11/2021 - 04/2005
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2004
10	AntiemeticsIBA 12/2021 - 09/2007
10	AnthracyclinesIBA 12/2021 - 09/2005
9	Trastuzumab (Herceptin)FDA Link 01/2023 - 11/2005
9	Docetaxel (Taxotere)FDA Link 01/2023 - 06/2007
9	Pamidronate (Aredia)FDA LinkGeneric 11/2021 - 01/2004
8	Denosumab FDA Link 11/2021 - 02/2013
8	taxaneIBA 10/2021 - 09/2005
8	Clodronic Acid (Clodronate)IBA 06/2021 - 01/2004
6	Estrogens (Estrogen)FDA Link 01/2020 - 03/2008
5	collagen type I trimeric cross-linked peptideIBA 09/2013 - 05/2006
4	Ibandronic Acid (Boniva)FDA Link 05/2021 - 04/2005
4	Fulvestrant (Faslodex)FDA Link 11/2018 - 11/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 05/2009
3	Tamoxifen FDA LinkGeneric 01/2022 - 10/2002
3	Aromatase InhibitorsIBA 01/2022 - 08/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 07/2014
3	Estrogen ReceptorsIBA 09/2021 - 07/2012
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2021 - 01/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 01/2020
3	Ciprofloxacin (Cipro)FDA LinkGeneric 08/2021 - 12/2016
3	Progesterone FDA LinkGeneric 01/2019 - 02/2012
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2015 - 01/2010
3	PlatinumIBA 04/2015 - 03/2014
3	Alkaline PhosphataseIBA 04/2014 - 10/2013
3	RANK LigandIBA 08/2013 - 02/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2013
2	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 08/2003
2	Vitamin D FDA LinkGeneric 11/2019 - 01/2010
2	Cholecalciferol (Vitamin D3)FDA Link 11/2019 - 01/2010
2	NVP-BKM120IBA 11/2018 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2018 - 01/2017
2	Alanine Transaminase (SGPT)IBA 11/2018 - 01/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 01/2017
2	Filgrastim (Neupogen)FDA Link 07/2018 - 04/2018
2	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 04/2016
2	Anastrozole (Arimidex)FDA LinkGeneric 11/2016 - 01/2015
2	Aprepitant (Emend)FDA Link 04/2016 - 07/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2015 - 04/2008
2	olaparibIBA 01/2013 - 09/2011
2	Capecitabine (Xeloda)FDA Link 11/2010 - 06/2007
2	CalciumIBA 01/2010 - 07/2009
2	Vinorelbine (Navelbine)FDA LinkGeneric 06/2007 - 06/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2007 - 08/2003
2	Collagen Type I (Type I Collagen)IBA 05/2006 - 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Doxycycline (Periostat)FDA LinkGeneric 01/2023
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	MagnesiumIBA 12/2021

Therapy/Procedure

83	Therapeutics 12/2023 - 02/2003
57	Drug Therapy (Chemotherapy) 01/2023 - 09/2005
7	Adjuvant Chemotherapy 10/2020 - 11/2003
6	Castration 05/2022 - 01/2021
5	Radiotherapy 12/2021 - 01/2004
4	Aftercare (After-Treatment) 01/2024 - 07/2012
3	Palliative Care (Palliative Therapy) 03/2014 - 10/2008
2	Segmental Mastectomy (Lumpectomy) 12/2021 - 09/2021
2	Estrogen Replacement Therapy 08/2015 - 03/2008
2	Precision Medicine 06/2014 - 03/2014
2	Complementary Therapies (Alternative Medicine) 02/2006 - 03/2005
1	Adjuvant Radiotherapy 12/2021
1	Treatment Delay 12/2021
1	Premedication 10/2021